Protez Pharmaceuticals, Inc. develops antibiotics for the hospital market. Its product pipeline includes Protez, an antibiotic; PZ-601, a carbapenem antibiotic; The company’s products are used in the treatment of drug-resistant and life-threatening infections. Protez Pharmaceuticals, Inc. was founded in 2003 and recently acquired by Novartis. Protez is a standalone subsidiary of Novartis headquartered in Malvern, Pennsylvania
Company Details
- Employees
- 9
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- protez.com
- Competitors
- Rich Pharmaceuticals, Inc., Life Sciences Greenhouse Investments, Sacyl Pharmaceuticals, Inc., Millenium Pharmaceuticals, Raft Pharmaceuticals, Tyna Pharmaceuticals Inc., Inflexion Pharmaceuticals LLC, Nelson Pharmaceuticals, LLC, Mountain View Pharmaceuticals, Inc., NaLiRo Clinical Research, LLC.
Protez Pharmaceuticals Questions
Protez Pharmaceuticals's website is protez.com
Protez Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/protez-pharmaceuticals
Protez Pharmaceuticals has
9 employees.
View email and phone details for 9
employees at Protez Pharmaceuticals.
Protez Pharmaceuticals's industry is
Biotechnology Research
Protez Pharmaceuticals's top competitors are
Rich Pharmaceuticals, Inc.,
Life Sciences Greenhouse Investments,
Sacyl Pharmaceuticals, Inc.,
Millenium Pharmaceuticals,
Raft Pharmaceuticals,
Tyna Pharmaceuticals Inc.,
Inflexion Pharmaceuticals Llc,
Nelson Pharmaceuticals, Llc,
Mountain View Pharmaceuticals, Inc.,
Naliro Clinical Research, Llc.
Protez Pharmaceuticals's categories are Biotechnology Research
Protez Pharmaceuticals's founding year is 2003
